Home • Features A to Z

Features A-Z

• A Pharmaceutical Hazard
• Actelion Dismisses Big Pharma Threat
• Amendments Set to Clear Ambiguity

• Beating the Big C

• Cancer's Costly Controversy
• Consolidation May Immunise UK Biotech Investors
• Contracting Out Clinical Trials

• Delay at the FDA
• Diabetic Drug Delivery Opens Up
• Drugmakers Braced for US Election Results

• Electronic Networking: From Physician to Prescription
• European Biotech's Funding Crisis

• For Bristol, a Steady Course May be Best Navigation

• Gaining Microwave Speed
• Go Czech for Biotech

• Indian Takeover Targets

• Japan's M&A Boom

• Pharma set for Costly Shopping Spree
• Pharming out a New Marketing Message

• Reality Bites: Disappointment in the R&D Sector
• Roche May Clinch Genentech Before Key Avastin Results

• The Biotech Effect
• The Future for Biotesting
• The Witty Answer to GSK's Future
• Tracking the Drug Trail

• Vytorin's Value to Improve

• Waters' Back-Up Plan

---

Home | New On This Site | Products & Services | Company A-Z | Industry Projects | Features | White Papers | Jobs & Careers | Industry News | Events & Exhibitions | Newsletter Sign-Up | Organisations | About Us | Contact Us | Advertise With Us |